Provided by Tiger Trade Technology Pte. Ltd.

Sana Biotechnology, Inc.

3.10
+0.18006.16%
Post-market: 3.10-0.0019-0.06%19:41 EDT
Volume:3.30M
Turnover:10.23M
Market Cap:825.73M
PE:-3.22
High:3.19
Open:2.98
Low:2.96
Close:2.92
52wk High:6.55
52wk Low:1.26
Shares:266.37M
Float Shares:168.00M
Volume Ratio:0.82
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9636
EPS(LYR):-0.9642
ROE:-118.70%
ROA:-26.00%
PB:5.13
PE(LYR):-3.22

Loading ...

Sana Biotechnology Q3 net loss narrows

Reuters
·
Nov 07, 2025

Sana Biotechnology reports Q3 cash position of $153.1 million and focuses pipeline on type 1 diabetes and in vivo CAR T programs

Reuters
·
Nov 07, 2025

BRIEF-Sana Biotechnology Q3 Operating Expenses USD 43.515 Million

Reuters
·
Nov 07, 2025

Press Release: Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates

Dow Jones
·
Nov 07, 2025

Sana Biotechnology options imply 17.5% move in share price post-earnings

TIPRANKS
·
Nov 07, 2025

Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit

GlobeNewswire
·
Nov 05, 2025

Sana Biotechnology Is Maintained at Market Outperform by Citizens

Dow Jones
·
Oct 30, 2025

Sana Biotechnology (SANA): Evaluating Valuation After Breakthrough Islet Cell Therapy and Surge in Market Interest

Simply Wall St.
·
Oct 20, 2025

Sana Biotechnology (SANA) Is Up 19.2% After Insulin Breakthrough in Diabetes Program and Strategic Refocus

Simply Wall St.
·
Oct 17, 2025

Small U.S. Stocks Rise; Sana Biotechnology Leads Increases

Dow Jones
·
Oct 16, 2025

Sana Biotech Stock — The Next '100-Bagger'?

Benzinga_recent_news
·
Oct 16, 2025

Sana Biotechnology Has Long-Term Growth Potential on Diabetes, CAR-T Therapies, Wedbush Says

MT Newswires Live
·
Sep 24, 2025

Sana Biotechnology Initiated at Outperform by Wedbush

Dow Jones
·
Sep 24, 2025

Sana Biotechnology Inc : Wedbush Initiates Coverage With Outperform Rating: Target Price $5

THOMSON REUTERS
·
Sep 24, 2025

Sana Biotechnology initiated with an Outperform at Wedbush

TIPRANKS
·
Sep 24, 2025

Wedbush Initiates Sana Biotechnology at Outperform With $5 Price Target

MT Newswires Live
·
Sep 24, 2025